Dr. Dejan Budimirovic, MD
Claim this profileKennedy Krieger Institute
Studies Fragile X Syndrome
Studies Syndrome
4 reported clinical trials
8 drugs studied
Area of expertise
1Fragile X Syndrome
FMR1 positive
FMR1
2Syndrome
FMR1 positive
FMR1
Affiliated Hospitals
Clinical Trials Dejan Budimirovic, MD is currently running
Zatolmilast
for Fragile X Syndrome
This trial is testing a medication called BPN14770 in boys with fragile X syndrome. The study aims to see how the medication moves through their bodies and if it helps with their symptoms.
Recruiting0 awards Phase 2 & 3
Cannabidiol Gel
for Fragile X Syndrome
This is a randomized, double-blind, placebo-controlled, multiple-center study, to assess the efficacy and safety of Cannabidiol administered as ZYN002 for the treatment of children, adolescent, and young adult patients with Fragile X Syndrome (FXS). Eligible participants will participate in up to an 18-week treatment period, where all participants will receive placebo or active study drug. Patients ages 3 to \< 30 years will be eligible to participate.
Recruiting1 award Phase 311 criteria
More about Dejan Budimirovic, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Dejan Budimirovic, MD has experience with
- Placebo
- Sulindac (HLX-0201)
- Gaboxadol (HLX-0206)
- BPN14770/ Zatolmilast
- BPN14770
- Zatolmilast
Breakdown of trials Dejan Budimirovic, MD has run
Fragile X Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dejan Budimirovic, MD specialize in?
Dejan Budimirovic, MD focuses on Fragile X Syndrome and Syndrome. In particular, much of their work with Fragile X Syndrome has involved FMR1 positive patients, or patients who are FMR1.
Is Dejan Budimirovic, MD currently recruiting for clinical trials?
Yes, Dejan Budimirovic, MD is currently recruiting for 3 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Dejan Budimirovic, MD has studied deeply?
Yes, Dejan Budimirovic, MD has studied treatments such as Placebo, Sulindac (HLX-0201), Gaboxadol (HLX-0206).
What is the best way to schedule an appointment with Dejan Budimirovic, MD?
Apply for one of the trials that Dejan Budimirovic, MD is conducting.
What is the office address of Dejan Budimirovic, MD?
The office of Dejan Budimirovic, MD is located at: Kennedy Krieger Institute, Baltimore, Maryland 21205 United States. This is the address for their practice at the Kennedy Krieger Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.